1475 related articles for article (PubMed ID: 28244671)
21. The role of FODMAPs in irritable bowel syndrome.
Shepherd SJ; Halmos E; Glance S
Curr Opin Clin Nutr Metab Care; 2014 Nov; 17(6):605-9. PubMed ID: 25255126
[TBL] [Abstract][Full Text] [Related]
22. Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms.
Barrett JS
Nutr Clin Pract; 2013 Jun; 28(3):300-6. PubMed ID: 23614962
[TBL] [Abstract][Full Text] [Related]
23. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Schumann D; Klose P; Lauche R; Dobos G; Langhorst J; Cramer H
Nutrition; 2018 Jan; 45():24-31. PubMed ID: 29129233
[TBL] [Abstract][Full Text] [Related]
24. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K
Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
Erickson J; Korczak R; Wang Q; Slavin J
Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
[TBL] [Abstract][Full Text] [Related]
26. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
27. A low FODMAP diet in patients with Crohn's disease.
Halmos EP
J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():14-5. PubMed ID: 26990906
[No Abstract] [Full Text] [Related]
28. [Insufficient evidence of the effect of the low FODMAP diet on irritable bowel syndrome].
Krogsgaard LR; Lyngesen M; Bytzer P
Ugeskr Laeger; 2015 Apr; 177(18):1503-7. PubMed ID: 25922242
[TBL] [Abstract][Full Text] [Related]
29. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Chumpitazi BP; Cope JL; Hollister EB; Tsai CM; McMeans AR; Luna RA; Versalovic J; Shulman RJ
Aliment Pharmacol Ther; 2015 Aug; 42(4):418-27. PubMed ID: 26104013
[TBL] [Abstract][Full Text] [Related]
30. Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn.
Liu J; Chey WD; Haller E; Eswaran S
Annu Rev Med; 2020 Jan; 71():303-314. PubMed ID: 31986083
[TBL] [Abstract][Full Text] [Related]
31. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.
Catassi G; Lionetti E; Gatti S; Catassi C
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300773
[TBL] [Abstract][Full Text] [Related]
32. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
[TBL] [Abstract][Full Text] [Related]
33. Review article: prebiotics in the gastrointestinal tract.
Macfarlane S; Macfarlane GT; Cummings JH
Aliment Pharmacol Ther; 2006 Sep; 24(5):701-14. PubMed ID: 16918875
[TBL] [Abstract][Full Text] [Related]
34. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
35. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
[TBL] [Abstract][Full Text] [Related]
36. Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters.
Grimaldi R; Swann JR; Vulevic J; Gibson GR; Costabile A
Br J Nutr; 2016 Aug; 116(3):480-6. PubMed ID: 27267934
[TBL] [Abstract][Full Text] [Related]
37. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders.
Huaman JW; Mego M; Manichanh C; Cañellas N; Cañueto D; Segurola H; Jansana M; Malagelada C; Accarino A; Vulevic J; Tzortzis G; Gibson G; Saperas E; Guarner F; Azpiroz F
Gastroenterology; 2018 Oct; 155(4):1004-1007. PubMed ID: 29964041
[TBL] [Abstract][Full Text] [Related]
38. Prebiotic supplementation over a cold season and during antibiotic treatment specifically modulates the gut microbiota composition of 3-6 year-old children.
Soldi S; Vasileiadis S; Lohner S; Uggeri F; Puglisi E; Molinari P; Donner E; Sieland C; Decsi T; Sailer M; Theis S
Benef Microbes; 2019 Apr; 10(3):253-263. PubMed ID: 30776899
[TBL] [Abstract][Full Text] [Related]
39. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease.
Hedin CR; McCarthy NE; Louis P; Farquharson FM; McCartney S; Stagg AJ; Lindsay JO; Whelan K
Clin Nutr; 2021 Aug; 40(8):5009-5019. PubMed ID: 34364241
[TBL] [Abstract][Full Text] [Related]
40. Prebiotic Supplementation During Pregnancy Modifies the Gut Microbiota and Increases Metabolites in Amniotic Fluid, Driving a Tolerogenic Environment
Brosseau C; Selle A; Duval A; Misme-Aucouturier B; Chesneau M; Brouard S; Cherbuy C; Cariou V; Bouchaud G; Mincham KT; Strickland DH; Barbarot S; Bodinier M
Front Immunol; 2021; 12():712614. PubMed ID: 34335628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
